This LIVE webinar is FREE
AACE Rare Endocrine Disease Series is pleased to present Recognizing and Treating X-Linked Hypophosphatemia a Lifelong Progressive Disease, a webinar designed to help clinicians create a path to diagnosis when encountering a patient with x-linked hypophosphatemia.
This disease was chosen due to its rarity, symptom complexity, and need for improved diagnostic and management strategies. The webinar will provide clinicians with the latest evidence-based guidelines, algorithms, consensus statements, and educational resources for diagnosing, managing, and treating these conditions. By highlighting the latest research and clinical advances, AACE aims to increase clinicians’ awareness, knowledge, and competence, ultimately improving the quality of care and outcomes for patients with this rare endocrine disease.
Recognizing and Treating X-Linked Hypophosphatemia a Lifelong Progressive Disease webinar will be held on Friday, October 4th at 1:00PM EDT.
Once you've completed the checkout process, go to AACE Learning Center and find the course in your "My Courses List." Opening the course will automatically register you for the webinar. You will receive an email invitation to the webinar and the ability to add it to your calendar.
2
1
10/4/2024 at 1:00pm EDT
12/31/2024
Upon completion of the program, participants will be able to:
- Describe the diagnostic and testing approach in evaluating a patient with a rare endocrine disease.
- Utilize evidence-based guidelines, algorithms, and consensus statements to diagnose and treat rare endocrine diseases.
- Identify and treat long-term complications and comorbidities of rare endocrine diseases.
This webinar is intended for endocrinologists and all members of the endocrine care team.
Mike Lewiecki, MD, FACE
Ranjodh Gill, MD, FACE, FACP, CCD
Physicians and Physician Assistants
The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American College of Endocrinology (ACE) designates this other/blended learning activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit.
Please allow two weeks for MOC points to appear within your account on the ABIM website. Participation information will be shared.
Nurses
American Association of Clinical Endocrinology is approved by the California Board of Registered Nursing, Provider Number 17762, for 1 contact hours.
Planner Disclosures
Basma Abdulhadi, MD: No relationships to disclose
Ranjodh Gill, MD, FACE, FACP, CCD: No relationships to disclose
Mike Lewiecki, MD, FACE: Angitia: Research Funding, Consultant; Amgen: Consultant, Speakers’ Bureau; Radius: Consultant, Speakers’ Bureau; Kyowa Kirin: Consulant, Speakers’ Bureau; Ascendis: Consultant, Speakers’ Bureau
Amy Ogunsunlade: No relationships to disclose
Speaker Disclosures
Mike Lewiecki, MD, FACE: Angitia: Research Funding, Consultant; Amgen: Consultant, Speakers’ Bureau; Radius: Consultant, Speakers’ Bureau; Kyowa Kirin: Consulant, Speakers’ Bureau; Ascendis: Consultant, Speakers’ Bureau
Ranjodh Gill, MD, FACE, FACP, CCD: No relationships to disclose
All of the relevant financial relationships listed for these individuals have been mitigated.
This activity is supported by educational grants from Kyowa Kirin.